Literature DB >> 22234610

A dual array-based approach to assess the abundance and posttranslational modification state of signaling proteins.

Katrin Luckert1, Taranjit S Gujral, Marina Chan, Mark Sevecka, Thomas O Joos, Peter K Sorger, Gavin Macbeath, Oliver Pötz.   

Abstract

A system-wide analysis of cell signaling requires detecting and quantifying many different proteins and their posttranslational modification states in the same cellular sample. Here, we present Protocols for two miniaturized, array-based methods, one of which provides detailed information on a central signaling protein and the other of which provides a broad characterization of the surrounding signaling network. We describe a bead-based array and its use in characterizing the different forms and functions of β-catenin, as well as lysate microarrays (reverse-phase protein arrays) and their use in detecting and quantifying proteins involved in the canonical and noncanonical Wnt signaling pathways. As an application of this dual approach, we characterized the state of β-catenin signaling in cell lysates and linked these molecule-specific data with pathway-wide changes in signaling. The Protocols described here provide detailed instructions for cell culture methods, bead arrays, and lysate microarrays and outline how to use these complementary approaches to obtain insight into a complex network at a systems level.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234610      PMCID: PMC3465074          DOI: 10.1126/scisignal.2002372

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  28 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

Review 2.  Protein microarrays: promising tools for proteomic research.

Authors:  Markus F Templin; Dieter Stoll; Jochen M Schwenk; Oliver Pötz; Stefan Kramer; Thomas O Joos
Journal:  Proteomics       Date:  2003-11       Impact factor: 3.984

3.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors.

Authors:  Barbara Lustig; Boris Jerchow; Martin Sachs; Sigrid Weiler; Torsten Pietsch; Uwe Karsten; Marc van de Wetering; Hans Clevers; Peter M Schlag; Walter Birchmeier; Jürgen Behrens
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

5.  P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells.

Authors:  Tolga Cagatay; Mehmet Ozturk
Journal:  Oncogene       Date:  2002-11-14       Impact factor: 9.867

6.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

Review 7.  Phospho-regulation of Beta-catenin adhesion and signaling functions.

Authors:  Rebecca Leadem Daugherty; Cara J Gottardi
Journal:  Physiology (Bethesda)       Date:  2007-10

8.  Profiling receptor tyrosine kinase activation by using Ab microarrays.

Authors:  Ulrik B Nielsen; Mike H Cardone; Anthony J Sinskey; Gavin MacBeath; Peter K Sorger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-22       Impact factor: 11.205

9.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.

Authors:  A de La Coste; B Romagnolo; P Billuart; C A Renard; M A Buendia; O Soubrane; M Fabre; J Chelly; C Beldjord; A Kahn; C Perret
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes.

Authors:  Cara J Gottardi; Barry M Gumbiner
Journal:  J Cell Biol       Date:  2004-10-18       Impact factor: 10.539

View more
  11 in total

1.  Representing dynamic biological networks with multi-scale probabilistic models.

Authors:  Alexander Groß; Barbara Kracher; Johann M Kraus; Silke D Kühlwein; Astrid S Pfister; Sebastian Wiese; Katrin Luckert; Oliver Pötz; Thomas Joos; Dries Van Daele; Luc De Raedt; Michael Kühl; Hans A Kestler
Journal:  Commun Biol       Date:  2019-01-17

2.  Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.

Authors:  Lawrence N Kwong; Genevieve M Boland; Dennie T Frederick; Timothy L Helms; Ahmad T Akid; John P Miller; Shan Jiang; Zachary A Cooper; Xingzhi Song; Sahil Seth; Jennifer Kamara; Alexei Protopopov; Gordon B Mills; Keith T Flaherty; Jennifer A Wargo; Lynda Chin
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

3.  Reverse Phase Protein Arrays for Compound Profiling.

Authors:  Nathan Moerke; Mohammad Fallahi-Sichani
Journal:  Curr Protoc Chem Biol       Date:  2016-09-13

4.  Suppression of host p53 is critical for Plasmodium liver-stage infection.

Authors:  Alexis Kaushansky; Albert S Ye; Laura S Austin; Sebastian A Mikolajczak; Ashley M Vaughan; Nelly Camargo; Peter G Metzger; Alyse N Douglass; Gavin MacBeath; Stefan H I Kappe
Journal:  Cell Rep       Date:  2013-03-07       Impact factor: 9.423

5.  Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays.

Authors:  T S Gujral; R L Karp; A Finski; M Chan; P E Schwartz; G MacBeath; P Sorger
Journal:  Oncogene       Date:  2012-09-03       Impact factor: 9.867

6.  Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells.

Authors:  Henning Kempf; Ruth Olmer; Alexandra Haase; Annika Franke; Emiliano Bolesani; Kristin Schwanke; Diana Robles-Diaz; Michelle Coffee; Gudrun Göhring; Gerald Dräger; Oliver Pötz; Thomas Joos; Erik Martinez-Hackert; Axel Haverich; Falk F R Buettner; Ulrich Martin; Robert Zweigerdt
Journal:  Nat Commun       Date:  2016-12-09       Impact factor: 14.919

7.  Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma.

Authors:  Megan Wu; Jennifer Guan; Chris Li; Simon Gunter; Labeeba Nusrat; Sheena Ng; Karan Dhand; Cindi Morshead; Albert Kim; Sunit Das
Journal:  Oncotarget       Date:  2017-07-17

8.  Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer.

Authors:  Thomas Bello; Claudia Paindelli; Luis A Diaz-Gomez; Anthony Melchiorri; Antonios G Mikos; Peter S Nelson; Eleonora Dondossola; Taranjit S Gujral
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-30       Impact factor: 11.205

9.  A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib.

Authors:  Tobias Sinnberg; Elena Makino; Marcel A Krueger; Ana Velic; Boris Macek; Ulrich Rothbauer; Nicola Groll; Oliver Pötz; Stefan Czemmel; Heike Niessner; Friedegund Meier; Kristian Ikenberg; Claus Garbe; Birgit Schittek
Journal:  EBioMedicine       Date:  2016-05-01       Impact factor: 8.143

10.  Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib.

Authors:  James A MacLeod; Yan Gao; Christine Hall; William J Muller; Taranjit S Gujral; Peter A Greer
Journal:  Oncotarget       Date:  2018-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.